Purple Biotech Ltd. (PPBT) is priced at $6.16 after the most recent trading session. At the very opening of the session, the stock price was $5.81 and reached a high price of $6.30, prior to closing the session it reached the value of $5.59. The stock touched a low price of $5.81.
Recently in News on January 18, 2021, Purple Biotech to Present at the B. Riley Oncology Investor Conference. Purple Biotech Ltd. (“Purple Biotech”) (NASDAQ/TASE: PPBT), a clinical-stage company advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, today announced that the Purple Biotech management team will present a corporate overview at the B. Riley Oncology Investor Conference, being held virtually January 20-21, 2021. You can read further details here
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free. .
Purple Biotech Ltd. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $7.25 on 02/10/21, with the lowest value was $3.75 for the same time period, recorded on 01/04/21.
Purple Biotech Ltd. (PPBT) full year performance was -12.00%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Purple Biotech Ltd. shares are logging -57.22% during the 52-week period from high price, and 180.00% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $2.20 and $14.40.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 1620226 for the day, which was evidently higher, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Purple Biotech Ltd. (PPBT) recorded performance in the market was 61.68%, having the revenues showcasing 49.15% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 107.87M, as it employees total of 9 workers.
Purple Biotech Ltd. (PPBT) in the eye of market guru’s
During the last month, 0 analysts gave the Purple Biotech Ltd. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 4.38, with a change in the price was noted +2.17. In a similar fashion, Purple Biotech Ltd. posted a movement of +54.39% for the period of last 100 days, recording 671,337 in trading volumes.
Purple Biotech Ltd. (PPBT): Stocks Technical analysis and Trends
Raw Stochastic average of Purple Biotech Ltd. in the period of last 50 days is set at 69.21%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 67.37%. In the last 20 days, the company’s Stochastic %K was 58.48% and its Stochastic %D was recorded 58.18%.
If we look into the earlier routines of Purple Biotech Ltd., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 61.68%. Additionally, trading for the stock in the period of the last six months notably improved by 17.20%, alongside a downfall of -12.00% for the period of the last 12 months. The shares increased approximately by -2.22% in the 7-day charts and went down by 24.70% in the period of the last 30 days. Common stock shares were driven by 49.15% during last recorded quarter.